Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

July 23, 2026 08:00 ET | Source: HCW Biologics Inc.

HCW Biologics Reaches Milestones for Its Proprietary Tetravalent Second-Generation T-Cell Engager Program On Track To Initiate Clinical Trials in First Half 2027

Company requested Type B pre-IND meeting with U.S. FDA to discuss development and regulatory strategy for its investigational tetravalent T-cell engager, HCW11-018b HCW11-018b has demonstrated...
November 18, 2024 07:00 ET | Source: HCW Biologics, Inc

HCW Biologics and WY Biotech Announce License Agreement for Immunotherapeutic Product Candidate

HCW Biologics signed license agreement with WY Biotech
November 14, 2024 16:40 ET | Source: HCW Biologics, Inc

HCW Biologics Reports Third Quarter 2024 Financial Results and Business Highlights

Press release for Q3 2024 business highlights and financial results
April 01, 2024 16:10 ET | Source: HCW Biologics, Inc

HCW Biologics Reports Fourth Quarter 2023 and Fiscal Year End Financial Results And Business Highlights

Q4 and Year End Earnings Release and Business Highlights
June 14, 2023 07:30 ET | Source: HCW Biologics, Inc

HCW Biologics is Granted Third Fundamental Patent: U.S. Patent for Methods of Treating Age-Related Disorders

MIRAMAR, Fla., June 14, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (“HCW Biologics” or the “Company”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and...